Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

RIPAZEPAM A NEW ANXIOLYTIC AGENT

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    RIPAZEPAM A NEW ANXIOLYTIC AGENT. Inpharma Wkly. 44, 13 (1976). https://doi.org/10.1007/BF03288490

    Download citation

    Keywords

    • Placebo
    • General Practice
    • Dosage Level
    • Dosage Group
    • 80mg Daily